Luminec Pharmaceuticals is now actively producing over 20 products based on our proprietary formulations Triamino™ and TAFA400™, enhanced by PH-713™. The company has plans for well over 40 products for specific treatments for humans and animals, to be applied orally, topically, via nebulizer, and intravenously.